Cargando…

N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide

In the title compound, C(32)H(35)BrN(4)O(3), the piperazine ring exists in a chair conformation. The quinoline ring system is oriented at dihedral angles of 82.70 (17) and 19.54 (17)° to the phenyl and meth­oxy­phenyl rings, respectively. Weak inter­molecular C—H⋯π inter­actions are present in the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Lei, Wang, Rui, Li, Chang-Yi, Wang, Zhi-Qiang, Sun, Tie-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247335/
https://www.ncbi.nlm.nih.gov/pubmed/22219953
http://dx.doi.org/10.1107/S1600536811040955
_version_ 1782220083698860032
author Yuan, Lei
Wang, Rui
Li, Chang-Yi
Wang, Zhi-Qiang
Sun, Tie-Min
author_facet Yuan, Lei
Wang, Rui
Li, Chang-Yi
Wang, Zhi-Qiang
Sun, Tie-Min
author_sort Yuan, Lei
collection PubMed
description In the title compound, C(32)H(35)BrN(4)O(3), the piperazine ring exists in a chair conformation. The quinoline ring system is oriented at dihedral angles of 82.70 (17) and 19.54 (17)° to the phenyl and meth­oxy­phenyl rings, respectively. Weak inter­molecular C—H⋯π inter­actions are present in the crystal structure.
format Online
Article
Text
id pubmed-3247335
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-32473352012-01-04 N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide Yuan, Lei Wang, Rui Li, Chang-Yi Wang, Zhi-Qiang Sun, Tie-Min Acta Crystallogr Sect E Struct Rep Online Organic Papers In the title compound, C(32)H(35)BrN(4)O(3), the piperazine ring exists in a chair conformation. The quinoline ring system is oriented at dihedral angles of 82.70 (17) and 19.54 (17)° to the phenyl and meth­oxy­phenyl rings, respectively. Weak inter­molecular C—H⋯π inter­actions are present in the crystal structure. International Union of Crystallography 2011-10-12 /pmc/articles/PMC3247335/ /pubmed/22219953 http://dx.doi.org/10.1107/S1600536811040955 Text en © Yuan et al. 2011 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Yuan, Lei
Wang, Rui
Li, Chang-Yi
Wang, Zhi-Qiang
Sun, Tie-Min
N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide
title N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide
title_full N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide
title_fullStr N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide
title_full_unstemmed N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide
title_short N-[(R)-(6-Bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-N-[(S)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide
title_sort n-[(r)-(6-bromo-2-meth­oxy­quinolin-3-yl)(phen­yl)meth­yl]-n-[(s)-1-(4-meth­oxy­phen­yl)eth­yl]-2-(piperazin-1-yl)acetamide
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247335/
https://www.ncbi.nlm.nih.gov/pubmed/22219953
http://dx.doi.org/10.1107/S1600536811040955
work_keys_str_mv AT yuanlei nr6bromo2methoxyquinolin3ylphenylmethylns14methoxyphenylethyl2piperazin1ylacetamide
AT wangrui nr6bromo2methoxyquinolin3ylphenylmethylns14methoxyphenylethyl2piperazin1ylacetamide
AT lichangyi nr6bromo2methoxyquinolin3ylphenylmethylns14methoxyphenylethyl2piperazin1ylacetamide
AT wangzhiqiang nr6bromo2methoxyquinolin3ylphenylmethylns14methoxyphenylethyl2piperazin1ylacetamide
AT suntiemin nr6bromo2methoxyquinolin3ylphenylmethylns14methoxyphenylethyl2piperazin1ylacetamide